AIM Revitafem®
Natural health product licensed in Canada
- Licence holder
- NAIM Canada Inc. o/a AIM Canada
- NPN or DIN-HM
- 80019000
- Status
- Active licence
- Licence date
- 27 May 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hespéridine Source : Pelure de pamplemousse | 50 mg | Not calculated |
| Hespéridine Source : Pelure d'orange | 50 mg | Not calculated |
| Hespéridine Source : Pelure de citron | 50 mg | Not calculated |
| Angelica sinensis Source : Racine Potency : 1 % ligustilide | 125 mg | Not calculated |
| Ginseng (Panax ginseng) Source : Racine Potency : 6 % ginsenosides | 50 mg | Not calculated |
| Dioscorea villosa Source : Racine | 50 mg | Not calculated |
| Glycine max Source : Fève Potency : 8.5 mg ÉAI Total isoflavones | 32.5 mg | Not calculated |
| Glycine max Source : Fève Potency : 0.9 mg ÉAI Genistein/genistin compounds | Not specified | Not calculated |
| Cimicifuga racemosa Source : Racine Potency : 2.5 % triterpene glycosides | 20 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hydroxypropyl methyl cellulose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Women's herbal formula to help menopausal symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80019000
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.